TRACON Pharmaceuticals Statistics
Total Valuation
TCON has a market cap or net worth of $101.93 million. The enterprise value is $91.02 million.
| Market Cap | 101.93M |
| Enterprise Value | 91.02M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TCON has 45.50 million shares outstanding. The number of shares has increased by 56.53% in one year.
| Shares Outstanding | 45.50M |
| Shares Change (YoY) | +56.53% |
| Shares Change (QoQ) | -11.15% |
| Owned by Insiders (%) | 2.60% |
| Owned by Institutions (%) | 11.66% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.27 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | 27.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.27, with an EV/FCF ratio of 24.76.
| EV / Earnings | n/a |
| EV / Sales | 7.56 |
| EV / EBITDA | 24.27 |
| EV / EBIT | 24.49 |
| EV / FCF | 24.76 |
Financial Position
The company has a current ratio of 0.89
| Current Ratio | 0.89 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -35.90% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $708,529 |
| Profits Per Employee | -$211,059 |
| Employee Count | 17 |
| Asset Turnover | 1.20 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.96% in the last 52 weeks. The beta is 1.04, so TCON's price volatility has been similar to the market average.
| Beta (1Y) | 1.04 |
| 52-Week Price Change | -93.96% |
| 50-Day Moving Average | 5.12 |
| 200-Day Moving Average | 4.50 |
| Relative Strength Index (RSI) | 35.22 |
| Average Volume (30 Days) | 227,653 |
Short Selling Information
The latest short interest is 744,915, so 1.64% of the outstanding shares have been sold short.
| Short Interest | 744,915 |
| Short Previous Month | 1.90M |
| Short % of Shares Out | 1.64% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, TCON had revenue of $12.05 million and -$3.59 million in losses. Loss per share was -$2.20.
| Revenue | 12.05M |
| Gross Profit | 12.05M |
| Operating Income | -9.27M |
| Pretax Income | -3.59M |
| Net Income | -3.59M |
| EBITDA | 3.75M |
| EBIT | 3.72M |
| Loss Per Share | -$2.20 |
Balance Sheet
The company has $8.64 million in cash and no debt, giving a net cash position of $8.64 million or $0.19 per share.
| Cash & Cash Equivalents | 8.64M |
| Total Debt | n/a |
| Net Cash | 8.64M |
| Net Cash Per Share | $0.19 |
| Equity / Book Value | -809,000 |
| Book Value Per Share | -0.02 |
| Working Capital | -1.09M |
Cash Flow
| Operating Cash Flow | 3.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | 3.68M |
| FCF Per Share | $2.25 |
Margins
Gross margin is 100.00%, with operating and profit margins of -76.99% and -29.79%.
| Gross Margin | 100.00% |
| Operating Margin | -76.99% |
| Pretax Margin | -29.79% |
| Profit Margin | -29.79% |
| EBITDA Margin | 31.13% |
| EBIT Margin | 30.85% |
| FCF Margin | 30.52% |
Dividends & Yields
TCON does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -56.53% |
| Shareholder Yield | -56.53% |
| Earnings Yield | -3.60% |
| FCF Yield | 3.69% |
Analyst Forecast
The average price target for TCON is $60.00, which is 2,596.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.00 |
| Price Target Difference | 2,596.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 64.43% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 10, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 10, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
TCON has an Altman Z-Score of -25.57 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.57 |
| Piotroski F-Score | 3 |